Role of nurses in the assessment and management of chemotherapy-related side effects in cancer patients

References

• Department of Health. The Nursing Contribution to Cancer Care. London, UK: Her Majesty’s Stationery Office; 2000a.
   Google Scholar
• Department of Health. The NHS Cancer Plan. London, UK: Her Majesty’s Stationery Office; 2000b.
   Google Scholar
• Department of Health. The Cancer Reform Strategy. London, UK: Her Majesty’s Stationery Office; 2007.
   Google Scholar
• Department of Health. Manual of Cancer Services; Chemotherapy measures version 2.0. London, UK: National Cancer Peer Review, National Cancer Action Team; 2013. Available from: http:/www.cquins.nhs.uk. Accessed September 20, 2013.
   Google Scholar
• Farrell C, Lennan E. Nurse-led chemotherapy clinics: issues for the prescriber. Nurse Prescribing. 2013;11:352–361.
   Google Scholar
• Lennan E, Vidall C, Roe H, Smith J, Farrell C. Best practice in nurse-led chemotherapy review: a position statement from the United Kingdom Oncology Nursing Society. London, UK: United Kingdom Oncology Nursing Society; 2012. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413734/. Accessed February 15, 2014.
   Google Scholar
• Skills for Health. http://www.skillsforhealth.org. [homepage on the Internet]. Accessed.
   Google Scholar
• National Prescribing Centre. A single competency framework for all prescribers. London, UK: National Prescribing Centre; 2012. Available from: http://www.npc.co.uk/improving_safety/improving_quality/resources/single_comp_framework.pdf. Accessed February 16, 2014.
   Google Scholar
• United Kingdom Oncology Nursing Society (UKONS). http://www.UKONS.org. [homepage on the Internet]. Accessed Sep 2013.
   Google Scholar
• National Confidential Enquiry into Patient Outcome and Death. For Better, for Worse? London, UK: National Confidential Enquiry into Patient Outcome and Death; 2008. Available from: http://www.ncepod.org.uk/2008sact.htm. Accessed February 14, 2014.
   Google Scholar
• National Patient Safety Agency. Risks of incorrect dosing of oral anti-cancer medicines. London, UK: National Patient Safety Agency; 2008. Available from: http://www.npsa.nhs.uk/corporate/news/patient-safety-risks-of-incorrect-dosing-of-oral-anti-cancer-medicines/. Accessed February 16, 2014.
   Google Scholar
• Molassiotis A, Brearley S, Saunders M, et al. Effectiveness of a home care nursing program in the symptom management of patients with colorectal and breast cancer receiving oral chemotherapy: a randomized, controlled trial. J Clin Oncol. 2009;27:6191–6198.
   PubMed Web of Science ®Google Scholar
• Ream E. I’m just in the shadow to keep an eye: an investigation to understand the need for support in family members of people having chemotherapy. Macmillan Cancer Care; 2013. Available from: http://public.ukcrn.org.uk/search/StudyDetail.aspx?StudyID=10054. Accessed February 16, 2014.
   Google Scholar
• Ream E, Pedersen V, Oakley C, Richardson A, Taylor C, Verity R. Informal carers’ experiences and needs when supporting patients through chemotherapy: a mixed method study. Eur J Cancer Care (Engl). 2013;22:797–806.
   Web of Science ®Google Scholar
• Hewitt M, Greenfield S, Stovall E. From cancer patient to cancer survivor. Lost in transition. Committee on Cancer Survivorship: Improving Care and Quality of Life National Cancer Policy Board; 2005. Available from: http://www.nap.edu/openbook.php?isbn=0309095956. Accessed February 15, 2014.
   Google Scholar
• National Cancer Survivorship Initiative. Concerns checklist. 2012. Available from: http://www.ncsi.org.uk/wp-content/uploads/MAC13689_Identifying-concerns_Pad_v3.pdf. Accessed February 16, 2014.
   Google Scholar
• Kearney N, McCann L, Norrie J, et al. Evaluation of a mobile phone-based, advanced symptom management system (ASyMS©) in the management of chemotherapy-related toxicity. Support Care Cancer. 2009;17:437–444.
   PubMed Web of Science ®Google Scholar
• Department of Health. Manual of Cancer Services; Acute Oncology Services. London, UK: National Cancer Peer Review, National Cancer Action Team; 2012. Available from: http:/www.cquins.nhs.uk Accessed September 20, 2013.
   Google Scholar
• MacMillan Cancer Support. Chemotherapy. 2001. Available from: http://www.macmillan.org.uk/Cancerinformation/Cancertreatment/Treatmenttypes/Chemotherapy/Chemotherapy.aspx. Accessed September 19, 2013.
   Google Scholar
• Cancer Research UK. How chemotherapy works. http://www.cancerresearchuk.org/cancer-help/about cancer/treatment/chemotherapy/about/how-chemotherapy-works. Accessed September 19, 2013.
   Google Scholar
• Quality Health. National Cancer Patient Experience Survey (2012–2013). Available from: http://www.quality-health.co.uk/surveys/national-cancer-patient-experience-survey. Accessed February 16, 2014.
   Google Scholar
• MacMillan Cancer Support. The hidden price of getting treatment. 2006. MacMillan Cancer Support. Available from: http://www.macmillan.org.uk/Documents/GetInvolved/Campaigns/Campaigns/Cancercosts.pdf. Accessed February 15, 2014.
   Google Scholar
• Oakley C, Lennan E, Roe H, Craven O, Harrold K, Vidall C. Safe practice and nursing care of patients receiving oral anti-cancer medicines; a position statement from UKONS. Ecancermedicalscience. 2010;4:177.
   Google Scholar
• Multinational Association of Supportive Care in Cancer. MASCC™ teaching tool for patients receiving oral agents for cancer. Available from: http://www.mascc.org/assets/documents/MOATT_English_2010.pdf. Accessed September 18, 2013.
   Google Scholar
• http://www.teachbacktraining.org/Institute. [homepage on the Internet]. Accessed November 13, 2013.
   Google Scholar
• Finnegan-John J, Foster R, Lennan E, et al. A longitudinal qualitative interview study to understand need for support in family members of people having chemotherapy. Psycho-Oncology. 2013;22 Suppl 1:1.
   Google Scholar
• National Cancer Institute. Cancer Therapy Evaluation Program. Common Toxicity Criteria Manual. Version 2.0. 1999. Available from: http://ctep.cancer.gov/protocolDevelopment/electronic_applications/docs/ctcmanual_v4_10-4-99.pdf. Accessed April 23, 2010.
   Google Scholar
• Baker J, Ajani J, Scotté F, et al. Docetaxel-related side effects and their management. Eur J Oncol Nurs. 2008;12:253–268.
   PubMed Web of Science ®Google Scholar
• National Institute for Clinical Excellence. Neutropenic sepsis: prevention and management of neutropenic sepsis in cancer patients Clinical guidelines, CG151. London, UK: National Institute for Clinical Excellence; 2012. Available from: http://publications.nice.org.uk/neutropenic-sepsis-prevention-and-management-of-neutropenic-sepsis-in-cancer-patients-cg151. Accessed February 16, 2014.
   Google Scholar
• Young A, Crowe M, Lennan E, et al. Delivery of chemotherapy at planned dose and on time. Cancer Nurs Pract. 2009;8:16–19.
   Google Scholar
• National Health Service. Available from http://www.tvcn.nhs.uk/index.aspx?o=12763. Accessed September 9, 2013.
   Google Scholar
• Hesketh PJ. Chemotherapy-induced nausea and vomiting. N Engl J Med. 2008;358:2482–2494.
   PubMed Web of Science ®Google Scholar
• Miller M, Kearney N. Chemotherapy-related nausea and vomiting – past reflections, present practice and future management. Eur J Cancer Care (Engl). 2004;13:71–81.
   PubMed Web of Science ®Google Scholar
• Grunberg SM. Chemotherapy-induced nausea and vomiting: prevention, detection, and treatment – how are we doing? J Support Oncol. 2004;2(Suppl 1):S1–S10.
   Google Scholar
• Hickok JT, Roscoe JA, Morrow GR, King DK, Atkins JN, Fitch TR. Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytriptamine-3 antiemetics: a University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program study of 360 cancer patients treated in the community. Cancer. 2003;97:2880–2886.
   PubMed Web of Science ®Google Scholar
• Armes J, Wagland R, Finnegan-John J, Richardson A, Corner J, Griffiths P. Development and testing of the patient-reported chemotherapy indicators of symptoms and experience: patient-reported outcome and process indicators sensitive to the quality of nursing care in ambulatory chemotherapy settings. Cancer Nurs. October 17, 2013. [Epub ahead of print.]
   Web of Science ®Google Scholar
• Vidall C, Dielenseger P, Farrell C, et al. Evidence-based management of chemotherapy-induced nausea and vomiting: a position statement from a European cancer nursing forum. Ecancermedicalscience. 2011;5:211.
   PubMedGoogle Scholar
• Middleton J, Lennan E. Effectively managing chemotherapy-induced nausea and vomiting. Br J Nurs. 2011;20:S7–S8, S10–S12, S14–S15.
   Google Scholar
• American Society of Clinical Oncology. Available from: http://www.asco.org/guidelines/chemotherapyinducednauseaandvomiting/. Accessed November 24, 2013.
   Google Scholar
• Dibble SL, Luce J, Cooper BA, et al. Acupressure for chemotherapy-induced nausea and vomiting: a randomized clinical trial. Oncol Nurs Forum. 2007;34:813–820.
   PubMed Web of Science ®Google Scholar
• Ezzo JM, Richardson MA, Vickers A, et al. Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting. Cochrane Database Syst Rev. 2006;2:CD002285.
   Web of Science ®Google Scholar
• Ernst E, Pittler MH. Efficacy of ginger for nausea and vomiting: a systematic review of the randomized clinical trials. Br J Anaesth. 2000;84:367–371.
   PubMed Web of Science ®Google Scholar
• Eckert RM. Understanding anticipatory nausea. Oncol Nurs Forum. 2001;28:1553–1558.
   PubMedGoogle Scholar
• Shelke AR, Roscoe JA, Morrow GR, Colman LK, Banerjee TK, Kirshner JJ. Effect of a nausea expectancy manipulation on chemotherapy-induced nausea: a university of Rochester cancer center community clinical oncology program study. J Pain Symptom Manage. 2008;35:381–387.
   Web of Science ®Google Scholar
• Benson AB 3rd, Ajani JA, Catalano RB, et al. Recommended guidelines for the treatment of cancer treatment-induced diarrhea. J Clin Oncol. 2004;22:2918–2926.
   PubMed Web of Science ®Google Scholar
• Kornblau S, Benson AB, Catalano R, et al. Management of cancer treatment-related diarrhea. Issues and therapeutic strategies. J Pain Symptom Manage. 2000;19:118–129.
   PubMed Web of Science ®Google Scholar
• Gebbia V, Carreca I, Testa A, et al. Subcutaneous octreotide versus oral loperamide in the treatment of diarrhea following chemotherapy. Anticancer Drugs. 1993;4:443–445.
   PubMed Web of Science ®Google Scholar
• Richardson G, Dobish R. Chemotherapy induced diarrhea. J Oncol Pharm Pract. 2007;13:181–198.
   PubMedGoogle Scholar
• Gibson RJ, Keefe DM. Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies. Support Care Cancer. 2006;14:890–900.
   PubMed Web of Science ®Google Scholar
• Massey C. A multicenter study to determine the efficacy and patient acceptability of the Paxman scalp cooler to prevent hair loss in patients receiving chemotherapy. Eur J Oncol Nurs. 2004;8:121–130.
   PubMedGoogle Scholar
• Roe H. Chemotherapy-induced alopecia: advice and support for hair loss. Br J Nurs. 2011a;20:S4–S11.
   Google Scholar
• Hilton S, Hunt K, Emslie C, Salinas M, Ziebland S. Have men been overlooked? A comparison of young men and women’s experiences of chemotherapy-induced alopecia. Psycho-Oncology. 2008;7:577–583.
   Google Scholar
• Yeager CE, Olsen EA. Treatment of chemotherapy-induced alopecia. Dermatol Ther. 2011;24:432–442.
   PubMed Web of Science ®Google Scholar
• Hunt NC. The Viviscal Report; the hidden impact of hair loss. 2009. Available from: http://www.managinghairloss.com/_pdf/Hair-loss-report-summary.pdf. Accessed January 5, 2014.
   Google Scholar
• Mynewhair. Advice and support if you lose your hair. 2011. Available from: http://www.mynewhair.org. Accessed September 15, 2013.
   Google Scholar
• Treister N, Sook-Bin W. Chemotherapy-induced oral mucositis. 2008. Available from: http://emedicine.medscape.com/article/1079570-overview. Accessed February 16, 2014.
   Google Scholar
• Borbasi Cameron K, Quested B, Olver I, To B, Evans D. More than a sore mouth: patients’ experience of oral mucositis. Oncol Nurs Forum. 2002;29:1051–1057.
   Google Scholar
• Mais K. Mucositis from radiotherapy to the head and neck: an overview. Oncology News. 2006;1. Available from: http://www.oncologynews.biz/pdf/jun_jul/ON_junjul06_18.pdf. Accessed February 16, 2014.
   Google Scholar
• UK Oral Mucositis in Cancer Group. OM guidelines. Available from http://www.ukomic.co.uk/new-om-guidelines.html. Accessed Sep 2013.
   Google Scholar
• Rehwaldt M, Wickham R. Purl S, et al. Self care strategies to cope with taste changes after chemotherapy. Oncology Nursing Forum. 2009;36(2):E47–E56.
   PubMedGoogle Scholar
• Sánchez-Lara K, Sosa-Sánchez R, Green-Renner D, et al. Influence of taste disorders on dietary behaviors in cancer patients under chemotherapy. Nutr J. 2010;9:15.
   PubMed Web of Science ®Google Scholar
• Steinback S, Hummel T, Böhner C, et al. Qualitative and quantitative assessment of taste and smell changes in patients undergoing chemotherapy for breast and gynecologic malignancies. J Clin Oncol. 2009;27:1899–1905.
   Web of Science ®Google Scholar
• Bernhardson BM, Tishelman C, Rutqvist LE. Self-reported taste and smell changes during cancer chemotherapy. Support Care Cancer. 2008;16:275–283.
   PubMed Web of Science ®Google Scholar
• Schlairet M, Heddon M, Griffis M. Piloting a needs assessment to guide development of a survivorship program for a community cancer center. Oncol Nurs Forum. 2010;37:501–508.
   Web of Science ®Google Scholar
• Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol. 2000;18:743–753.
   PubMed Web of Science ®Google Scholar
• Broeckel JA, Jacobsen PB, Horton J, Balducci L, Lyman GH. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol. 1998;16:1689–1696.
   PubMed Web of Science ®Google Scholar
• Nyholm CB. Side effects of cancer treatment: “chemo head” chemotherapy causes chemo brain. Available from: http://voices.yahoo.com/side-effects-cancer-treatment-chemo-head-389300.html?cat=68 Accessed February 16, 2014.
   Google Scholar
• British Pharmacological Society. 2013. Available from: http://www.bps.ac.uk/view/index.html. Accessed February 14, 2014.
   Google Scholar
• Resuscitation Council. Emergency treatment of anaphylactic reactions. Guidelines for healthcare providers. Available from http://www.resus.org.uk/pages/reaction.pdf#search=%E2%80%9Danaphylaxis2. Accessed September 16, 2013.
   Google Scholar
• Lee C, Gianos M, Klaustermeyer W. Diagnosis and management of hypersensitivity reactions related to common chemotherapy agents. Ann Allergy Asthma Immunol. 2009;102:179–187.
   PubMed Web of Science ®Google Scholar
• http://www.neuropathy.org/site/PageServer. [webpage on the Internet]. Accessed Dec 2013.
   Google Scholar
• Pérez Fidalgo JA, García Fabregat L, Cervantes A, Margulies A, Vidall C, Roila F; ESMO Guidelines Working Group. Management of chemotherapy extravasation; ESMO-EONS clinical practice guidelines. Eur J Oncol Nurs. 2012;16:528–534.
   Web of Science ®Google Scholar
• Schulmeister L. Extravasation management; clinical update. Semin Oncol Nurs. 2011;27:82–90.
   PubMedGoogle Scholar
• Roe H. Anthracycline extravasations; prevention and management. Br J Nurs. 2011b;20:S16–S22.
   Google Scholar
• Vidall C, Roe H, Dougherty L, Harrold K. Dexrazonane: a management option for anthracycline extravasations. Br J Nurs. 2013;22: S6–S12.
   Google Scholar
• United Kingdom Oncology Nursing Society. Anthracycline Extravasation Management Guidelines. London, UK: United Kingdom Oncology Nursing Society; 2008.
   Google Scholar
• National Cancer Institute Common toxicity criteria http://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm. [webpage on the Internet]. Accessed December 30, 2013.
   Google Scholar
• DPfizer Oncology. Acute Oncology Service: implementation of a nurse-led, integrated acute oncology service – Pan Birmingham Cancer Network and Sandwell and West Birmingham Hospitals NHS Trust. Available from: http://connect.qualityincare.org/oncology/patient_safety/case_studies/acute_oncology_service_implementation_of_a_nurse_led,_integrated_acute_oncology_service_pan_birmingham_cancer_network_and_sandwell_and_west_birmingham_hospitals_nhs_trust. [webpage on the Internet]. Accessed December 30, 2013.
   Google Scholar
• National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0. Available from: http://evs.nci.nih.gov/ftp1/CTCAE/CTCAE_4.03_2010-06-14_QuickReference_8.5x11.pdf. Accessed February 2012.
   Google Scholar